The Gaudium IVF IPO GMP has started showing activity in the grey market ahead of its public issue opening. Investors are closely tracking the Gaudium IVF IPO Grey Market Premium (GMP).
As of 19 February 2026, the Gaudium IVF IPO GMP is ₹12, reflecting improving investor sentiment.
Gaudium IVF IPO GMP Live Update
| Date | IPO GMP | GMP Trend | Estimated Gain |
|---|---|---|---|
| 19 Feb 2026 | ₹12 | IPO GMP UP | 15.19% |
| 18 Feb 2026 | ₹10 | IPO GMP UP | 12.66% |
| 17 Feb 2026 | ₹10 | IPO GMP UP | 12.66% |
| 16 Feb 2026 | – | – | – |
GMP Movement
- Previous GMP: ₹10
- Current GMP: ₹12
- Change: +₹2
Expected Listing Price Calculation
- Upper Price Band: ₹79
- Current GMP: ₹12
- Estimated Listing Price: ₹91
- Estimated Listing Gain: ~15.19%
Note: GMP is unofficial and may fluctuate before listing.
IPO Quick Overview
- IPO Open Date: 20 February 2026
- IPO Close Date: 24 February 2026
- Issue Size: ₹165 Crores
- Price Band: ₹75 – ₹79
- Lot Size: 189 Shares
- Listing: BSE & NSE
Business Overview – Gaudium IVF
Founded in March 2015, Gaudium IVF is a leading fertility treatment chain in India. The company operates across 30+ locations, including 7 hub centres and 28 spokes.
The company provides a wide range of fertility treatments, including:
- In Vitro Fertilisation (IVF)
- Intracytoplasmic Sperm Injection (ICSI)
- Intrauterine Insemination (IUI)
- Ovulation Induction
- PCOD/PCOS and Endometriosis care
- Male infertility treatments, including advanced sperm retrieval
Gaudium IVF also caters to international patients from countries such as Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman.
Conclusion
The rise in Gaudium IVF’s IPO GMP to ₹12 on 19 February 2026 signals strengthening grey-market interest ahead of the IPO opening tomorrow. However, investors should focus on company fundamentals rather than relying solely on GMP trends.
Stay connected for daily updates on the Gaudium IVF IPO subscription status, allotment, and listing-day performance.
Share
